Karen Geoffroy

5PUBLICATIONS
11CO-AUTHORS
Haematological tumoursMolecular targetsPredictive and prognostic markersTissue engineeringCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 28, 2025
The Immunoproteasome Is Expressed but Dispensable for a Leukemia Infected Cell Vaccine.

Delphine Béland, Victor Mullins-Dansereau, Karen Geoffroy

|Jan 08, 2025
The Small GTPase Ran Increases Sensitivity of Ovarian Cancer Cells to Oncolytic Vesicular Stomatitis Virus.

Karen Geoffroy, Mélissa Viens, Emma Mary Kalin

|Jun 10, 2022
High Levels of MFG-E8 Confer a Good Prognosis in Prostate and Renal Cancer Patients.

Karen Geoffroy, Patrick Laplante, Sylvie Clairefond

|Apr 23, 2022
MFG-E8 Reduces Aortic Intimal Proliferation in a Murine Model of Transplant Vasculopathy.

Benoit Brilland, Patrick Laplante, Pamela Thebault

|May 12, 2021
Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination.

D G Roy, K Geoffroy, M Marguerie

Pageof 1